Publication | Open Access
Chemoprevention in Patients with Peutz-Jeghers Syndrome: Lessons Learned
26
Citations
7
References
2018
Year
Due to accrual problems, no conclusions can be drawn about the value of everolimus in PJS treatment, questioning the feasibility of this agent for chemoprevention.
| Year | Citations | |
|---|---|---|
Page 1
Page 1